4-1717190-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001127266.2(TMEM129):c.1079C>T(p.Thr360Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000259 in 1,312,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001127266.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM129 | NM_001127266.2 | c.1079C>T | p.Thr360Ile | missense_variant | 4/4 | ENST00000382936.8 | NP_001120738.1 | |
TMEM129 | NM_138385.4 | c.*220C>T | 3_prime_UTR_variant | 3/3 | NP_612394.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM129 | ENST00000382936.8 | c.1079C>T | p.Thr360Ile | missense_variant | 4/4 | 1 | NM_001127266.2 | ENSP00000372394 | P1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000214 AC: 2AN: 93432Hom.: 0 AF XY: 0.0000205 AC XY: 1AN XY: 48702
GnomAD4 exome AF: 0.0000259 AC: 34AN: 1312614Hom.: 0 Cov.: 34 AF XY: 0.0000267 AC XY: 17AN XY: 636534
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | The c.1079C>T (p.T360I) alteration is located in exon 4 (coding exon 4) of the TMEM129 gene. This alteration results from a C to T substitution at nucleotide position 1079, causing the threonine (T) at amino acid position 360 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at